Longitudinal antibody repertoire in “mild” versus “severe” COVID-19 patients reveals immune markers associated with disease severity and resolution
Ravichandran S., Lee Y., Grubbs G., Coyle EM., Klenow L., Akasaka O., Koga M., Adachi E., Saito M., Nakachi I., Ogura T., Baba R., Ito M., Kiso M., Yasuhara A., Yamada S., Sakai-Tagawa Y., Iwatsuki-Horimoto K., Imai M., Yamayoshi S., Yotsuyanagi H., Kawaoka Y., Khurana S.
SARS-CoV-2–induced human antibody repertoire in patients with COVID-19 reveals immune markers of disease severity and recovery.